RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0034-1371869
Osteocalcin Induces Growth Hormone/Insulin-Like Growth Factor-1 System by Promoting Testosterone Synthesis in Male Mice
Publikationsverlauf
received 28. November 2013
accepted 06. März 2014
Publikationsdatum:
01. April 2014 (online)
Abstract
Osteocalcin has been shown to enhance testosterone production in men. In the present study, we investigated the effects of osteocalcin on testosterone and on induction of the growth hormone/insulin-like growth factor-1 axis. Osteocalcin injection stimulated growth, which could be inhibited by castration. In addition, osteocalcin induced testosterone secretion in testes both in vivo and in vitro. Using real-time polymerase chain reaction and Western blotting, we showed that growth hormone expression was significantly increased in the pituitary after osteocalcin injection (p<0.05). Growth hormone expression in CLU401 mouse pituitary cells was also significantly stimulated (p<0.05) by osteocalcin-induced MA-10 cells. Osteocalcin injection also promoted hepatic expression of growth hormone receptor and insulin-like growth factor-1 (p<0.05), as demonstrated by real-time polymerase chain reaction and Western blotting. Similarly, osteocalcin-induced MA-10 cells promoted growth hormone receptor and insulin-like growth factor-1 expression in NCTC1469 cells. These results suggest that the growth-stimulating activities of osteocalcin are mediated by testicular testosterone secretion, and thus provide valuable information regarding the regulatory effects of osteocalcin expression on the growth hormone/insulin-like growth factor-1 axis via reproductive activities.
-
References
- 1 Harada S-i, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature 2003; 423: 349-355
- 2 Rodan GA. Introduction to bone biology. Bone 1992; 13: S3-S6
- 3 Martin R. Toward a unifying theory of bone remodeling. Bone 2000; 26: 1-6
- 4 Olsen BR, Reginato AM, Wang W. Bone development. Annu Rev Cell Dev Biol 2000; 16: 191-220
- 5 Eriksen EF. Cellular mechanisms of bone remodeling. Rev Endocr Metab Disord 2010; 11: 219-227
- 6 Martin TJ, Sims NA, Quinn JM. Interactions among osteoblasts, osteoclasts, and other cells in bone. Osteoimmunology: interactions of the immune and skeletal systems. London: Academic Press; 2010: 227-268
- 7 Zengin A, Zhang L, Baldock PA, Sainsbury A. Neuropeptide Y and sex hormone interactions in humoral and neuronal regulation of bone and fat. Trends Endocrinol Metab 2010; 21: 411-418
- 8 Jones KB, Mollano AV, Morcuende JA, Cooper RR, Saltzman CL. Bone and brain: a review of neural, hormonal, and musculoskeletal connections. Iowa Orthop J 2004; 24: 123-132
- 9 Walker WH. Molecular mechanisms of testosterone action in spermatogenesis. Steroids 2009; 74: 602-607
- 10 Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000; 100: 197-207
- 11 Karsenty G. Update osteocalcin biology. Bone 2012; 51: S12-S13
- 12 Ducy P. The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism. Diabetologia 2011; 54: 1291-1297
- 13 Clemens TL, Karsenty G. The osteoblast: an insulin target cell controlling glucose homeostasis. J Bone Miner Res 2011; 26: 677-680
- 14 Oury F, Sumara G, Sumara O, Ferron M, Chang H, Smith CE, Hermo L, Suarez S, Roth BL, Ducy P, Karsenty G. Endocrine regulation of male fertility by the skeleton. Cell 2011; 144: 796-809
- 15 Mauras N, Rogol AD, Haymond MW, Veldhuis JD. Sex steroids, growth hormone, insulin-like growth factor-1: neuroendocrine and metabolic regulation in puberty. Horm Res Paediatr 1996; 45: 74-80
- 16 Christoforidis A, Maniadaki I, Stanhope R. Growth hormone/insulin-like growth factor-1 axis during puberty. Pediatr Endocrinol Rev 2005; 3: 5-10
- 17 Strobl JS, Thomas M. Human growth hormone. Pharmacol Rev 1994; 46: 1-34
- 18 Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 2001; 229: 141-162
- 19 Clark R. The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function. Endocr Rev 1997; 18: 157-179
- 20 Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J. Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 1994; 15: 369-390
- 21 Hoffman DM, O’Sullivan A, Ho K, Baxter RC. Diagnosis of growth-hormone deficiency in adults. Lancet 1994; 343: 1064-1068
- 22 Melmed S. Acromegaly pathogenesis and treatment. J Clin Invest 2009; 119: 3189
- 23 Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR, LeRoith D. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 2002; 110: 771-781
- 24 Karsenty G. Bone endocrine regulation of energy metabolism and male reproduction. C R Biol 2011; 334: 720-724
- 25 Ohlsson C, Bengtsson B-Å, Isaksson OG, Andreassen TT, Slootweg MC. Growth hormone and bone. Endocr Rev 1998; 19: 55-79
- 26 Giustina A, Mazziotti G, Canalis E. Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 2008; 29: 535-559
- 27 De la Piedra C, Larrañaga J, Castro N, Horcajada C, Rapado A, Herrera Pombo JL, Carbó E. Correlation among plasma osteocalcin, growth hormone, and somatomedin C in acromegaly. Calcif Tissue Int 1988; 43: 44-45
- 28 Doull I, Freezer N, Holgate S. Osteocalcin, growth, and inhaled corticosteroids: a prospective study. Arch Dis Child 1996; 74: 497-501
- 29 Ivaska KK, Käkönen S-M, Gerdhem P, Obrant KJ, Pettersson K, Väänänenl HK. Urinary osteocalcin as a marker of bone metabolism. Clin Chem 2005; 51: 618-628
- 30 Kirmani S, Atkinson EJ, Melton LJ, Kirmani S, Atkinson EJ, Melton 3rd LJ, Riggs BL, Amin S, Khosla S. J Bone Miner Res 2011; 26: 2212-2216
- 31 Bhasin S, Woodhouse L, Casaburi R, Singh AB, Bhasin D, Berman N, Chen X, Yarasheski KE, Magliano L, Dzekov C, Dzekov J, Bross R, Phillips J, Sinha-Hikim I, Shen R, Storer TW. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 2001; 281: E1172-E1181
- 32 Vingren JL, Kraemer WJ, Ratamess NA, Anderson JM, Volek JS, Maresh CM. Testosterone physiology in resistance exercise and training. Sports medicine 2010; 40: 1037-1053